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Painting subsensitizing doses of contact sensitizers on skin (low dose tolerization) 
induces antigen-specific tolerance, known as low zone tolerance (LZT), which has 
been experimentally demonstrated by inhibition of contact hypersensitivity (CHS). 
Although LZT was resulted from inhibition of the sensitization phase, the effects on 
the effector/elicitation phase remain unknown. L-selectin and ICAM-1 regulate 
leukocyte influx into inflamed tissues during the elicitation phase of CHS. LZT was 
investigated in mice lacking either L-selectin or ICAM-1 to evaluate the roles these 
leukocyte receptors playing in LZT during the elicitation phase. Low dose tolerization 
effectively suppressed CHS in wild type and L-selectin-deficient mice, but not in 
ICAM-1-deficient mice. Low dose tolerized ICAM-1-deficient splenocytes 
effectively suppressed the elicitation phase in naïve wild type recipients. Sensitized 
ICAM-1-deficient splenocytes exhibited normal proliferative responses to the 
sensitizing antigen and generated normal CHS in wild type recipients. Thus, ICAM-1 
deficiency did not affect the sensitization. LZT associated with a lack of ICAM-1 up-
regulation after elicitation, suggesting a potentially mechanistic role for ICAM-1. 
Blockade of IL-10, a possible mediator of LZT, produced by hapten-specific 
suppressor cells, abrogated LZT and restored ICAM-1 up-regulation. These results 
indicate that low dose tolerization controls CHS by abrogating ICAM-1 up-regulation 




 There are several established animal models of acquired peripheral tolerance 
in which mature lymphocytes in peripheral lymphoid tissues are rendered 
nonfunctional or hyporesponsive to specific antigens. Ultraviolet (UV) exposure or 
low, subimmunogenic doses of antigen are two ways to induce antigen-specific 
peripheral tolerance (Maurer et al., 2003; Ullrich, 1995). When antigen is repeatedly 
applied epicutaneously, low zone tolerance (LZT) is established. Because LZT is 
achieved by the physiological uptake of very small amounts of allergenic antigens 
through skin (low dose tolerization), it is widely regarded as a highly relevant model 
of naturally occurring tolerance to contact immunogens. Transfer of lymphoid 
components from tolerized donors induces LZT in naive recipients (Maurer et al., 
2003). Therefore, one of the possible mechanisms of LZT is the generation of 
antigen-specific suppressor cells, which would inhibit the generation and activation of 
effector T cells. 
 LZT is demonstrated by the inhibition of cellular immune responses, such as 
contact hypersensitivity (CHS). CHS consists of two phases, the sensitization phase 
and the elicitation phase. Although much is known about the sensitization phase, little 
is known about the elicitation phase (Grabbe et al., 1996). Similarly, while the 
suppressor T cells generated in low dose tolerization can suppress the sensitization 
phase by an IL-10-dependent pathway, the effect of these cells on the elicitation phase 
remains unknown (Maurer et al., 2003). Recent findings have demonstrated that the 
elicitation phase of CHS is regulated by various factors including cytokines and 
inflammatory cells at the sites of elicitation (Grabbe and Schwarz, 1998). Resident 
skin cells, mainly keratinocytes, are likely to initiate the elicitation phase of CHS 
responses by producing proinflammatory cytokines (Grabbe and Schwarz, 1998; 
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Piguet et al., 1991). A stimulatory role is attributed primarily to tumor necrosis factor 
(TNF)- since intradermal injection of this cytokine results in CHS-like skin 
inflammation (Grabbe and Schwarz, 1998; Granstein et al., 1986; Piguet et al., 1991). 
Expression of cell adhesion molecules also regulates the capacity to elicit CHS 
responses, since leukocyte recruitment into inflamed sites is achieved using specific 
constitutive or inducible adhesion molecules (Butcher, 1991; Fujimoto et al., 1999; 
Grabbe and Schwarz, 1998; Springer, 1995). L-selectin is constitutively expressed by 
most leukocytes, while P-selectin and E-selectin are expressed by activated 
endothelial cells (Tedder et al., 1999). Interaction with its ligand of N-glycan-linked 
6-sulfo sialyl Lewis X, L-selectin mediates leukocyte capture and rolling on the 
endothelium (Mitoma et al., 2007; Tedder et al., 1999). L-selectin-deficient (L-
selectin-/-)
 
mice consistently exhibit decreased CHS responses (Staite et al., 1996; 
Steeber et al., 1999). ICAM-1 is constitutively expressed by endothelial cells and is 
rapidly up-regulated by the local release of proinflammatory cytokines, including 
TNF-(Butcher, 1991; Springer, 1995). The interaction of ICAM-1 with 2 integrins 
on leukocytes enhances rolling, firm adhesion, and transmigration of leukocytes at 
sites of inflammation (Butcher, 1991; Springer, 1995; Tedder et al., 1999). 
Furthermore, ICAM-1 deficiency inhibits the elicitation phase of CHS responses 
without affecting the sensitization phase (Steeber et al., 1999).  
 In the current study, we investigated the roles of low dose tolerization-induced 
suppressor cells on the elicitation phase of CHS responses. We found that low dose 
tolerization-induced suppressor cells affected the elicitation phase of CHS by 





Low dose tolerization inhibits ICAM-1 up-regulation after antigen challenge 
The elicitation phase of CHS is dependent upon inflammatory cell infiltration, which 
is tightly regulated by cell adhesion molecules, including ICAM-1. ICAM-1 is 
constitutively expressed on vascular endothelial cells and the expression is strongly 
up-regulated during the elicitation phase of CHS (McHale et al., 1999). To address 
the role of ICAM-1 during LZT, we first examined ICAM-1 mRNA production 
following antigen challenge in mice that had either undergone low dose tolerization 
and sensitization, sensitization only, or challenge only. For low dose tolerization, 
mice were painted 5 times with tolerizing doses of 2,4,6-trinitro-1-chlorobenzene 
(TNCB) onto back skin. Then, mice were sensitized by TNCB onto the back skin. 
Five days later, ears were elicited. Total RNA samples, collected from ears taken 12 
hours after the elicitation of CHS, were used for semi-quantitative real-time PCR 
analysis of ICAM-1 expression (Figure 1). CHS induced a greater than ten-fold up-
regulation of ICAM-1 production when compared with elicitation without 
sensitization (P < 0.05). This up-regulation was diminished in mice that had 
undergone low dose tolerization before sensitization. Thus, low dose tolerization 
abrogated ICAM-1 up-regulation at the elicitation site. 
Low dose tolerization does not suppress CHS in ICAM-1-/- mice 
For further analysis of the effects of low dose tolerization on adhesion molecules, 
LZT was assessed in ICAM-1-/- mice, which can not express or up-regulate ICAM-1, 
L-selectin-/- mice, and double knockout ICAM-1/L-selectin-/- mice. Mice were 
sensitized by TNCB onto the back skin after low dose tolerization. Five days later, 
ears were challenged and ear swelling was measured after 48 hours. In wild type mice, 
low dose tolerization inhibited the elicitation phase (swelling decreased by 55%, P < 
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0.0001; Figure 2). Histopathology of the ear sections showed that inhibition of ear 
swelling was associated with a reduction in both oedema and leukocyte infiltration 
(data not shown). CHS responses were reduced in L-selectin-/- mice (54% decrease, P 
< 0.001), ICAM-1-/- mice (48%, P < 0.005), and L-selectin/ICAM-1-/- mice (85%, p < 
0.0001), relative to wild type mice (Figure 2). Low dose tolerization significantly 
suppressed CHS responses in L-selectin-/- mice (68% decrease, P < 0.001) compared 
to L-selectin-/- mice without tolerization. By contrast, ICAM-1-/- mice did not exhibit 
LZT (Figure 2). Interestingly, low dose tolerization suppressed CHS responses in wild 
type mice to a similar level to that observed in ICAM-1-/- mice that had not 
undergone tolerization. Thus, these results suggest that LZT is dependent on ICAM-1 
expression. 
ICAM-1 deficiency does not affect antigen-specific proliferative responses 
Since ICAM-1 can provide costimulatory signals for T cell activation during 
sensitization, we assessed whether the loss of LZT in ICAM-1-/- mice resulted from 
impaired antigen presentation, and generation of antigen-specific effector cells. 
Antigen-specific proliferative responses to 2,4,6-trinitro-benzenesulfonic acid (TNBS, 
a water soluble analog of TNCB) were analyzed. Five days after sensitization, 
splenocytes were isolated and cultured in vitro with TNBS for 5 days. In sensitized 
animals, similar splenocyte proliferation was observed at 20mM TNCB in both 
ICAM-1-/- mice and wild type mice, when compared with unsensitized mice (P < 0.03 
and P < 0.01, respectively, Figure 3). Low dose tolerization did not affect 
proliferation in sensitized ICAM-1-/- (P = 0.14) or wild type mice (P = 0.26) at 20mM 
TNCB. For further analysis, antigen-specific proliferative responses TNBS  were 
analyzed using lymph node cells, since these cells may include high number of 
immunized T cells. Low dose tolerization did not affect proliferation in sensitized 
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ICAM-1-/- or wild type mice. In addition, the response was significantly decreased in 
CD8+ depleted lymph node cells in both ICAM-1-/- (P < 0.03) and wild type mice (P 
< 0.05), suggesting that CD4+ cells may suppress the antigen specific proliferative 
response. Thus, ICAM-1 deficiency did not affect the generation of antigen-specific 
effector cells. 
ICAM-1 is not required for the generation and function of suppressor T cells 
Low dose tolerization generates T suppressor cells that can be transferred to naive 
mice by adoptive transfer of splenocytes (Seidel-Guyenot et al., 2006). We assessed 
the effect of ICAM-1 deficiency on the generation and function of these suppressor 
cells using adoptive transfer experiments. Seven days after TNCB sensitization 
following low dose tolerization, splenocytes from donor mice were transferred into 
naive recipients that were subsequently sensitized by TNCB. After 5 days, recipient 
mice were challenged on the ear and ear thickness was measured 48 hours later. Wild 
type mice that had received splenocytes from sensitized wild type or sensitized 
ICAM-1-/- donors exhibited normal CHS responses (Figure 4A). The transfer of 
splenocytes from low dose tolerized wild type mice into wild type recipients resulted 
in a significantly reduced CHS response compared to wild type recipients that 
received splenocytes from sensitized wild type mice (by 59%, p < 0.001). However, 
this reduction was completely abrogated by CD8+ cell depletion from donor cells. 
Similarly, adoptively transferred spleen cells from tolerized ICAM-1-/- donors 
suppressed the CHS response in wild type recipients (by 61%, P < 0.001). Thus, the 
generation and function of suppressor activity did not require ICAM-1 expression. By 
contrast, the transfer of splenocytes from low dose tolerized wild type donors into 
ICAM-1-/- recipients did not suppress the CHS response (Figure 4B). These results 
suggest that LZT requires ICAM-1 expression in recipients.   
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Suppressor cells inhibit effector cells during the elicitation phase of CHS 
Previous studies have shown that UV-induced suppressor cells can attenuate the 
elicitation phase of CHS as well as the sensitization phase (Komura et al., 2003). To 
assess the function of low dose tolerization-induced suppressor cells on the elicitation 
phase, we conducted further adoptive transfer studies. Naive wild type recipients 
received intravenously a mixture of spleen cells from sensitized wild type donors 
containing effector cells and the same number of spleen cells from low dose tolerized 
wild type donors containing antigen-specific suppressor cells. After 5days, the ears of 
unsensitized recipients were challenged and the ear swelling responses were evaluated. 
A normal CHS response was induced by the transfer of splenocytes from sensitized 
wild type donors into naive wild type recipients (Figure 5A). Co-transfer of 
splenocytes from low dose tolerized wild type donors along with splenocytes from 
sensitized wild type donors significantly suppressed CHS responses compared to wild 
type recipients of splenocytes from sensitized donors (by 61%, P < 0.005). Therefore, 
tolerized suppressor cells can inhibit the effector cells during the elicitation phase of 
the CHS response. By contrast, co-transfer of splenocytes from sensitized wild type 
donors along with those from low dose tolerized wild type donors into ICAM-1-/- 
recipients did not result in further suppression of the response when compared to the 
transfer of cells only from sensitized wild type donors (Figure 5B). These results 
suggest that LZT requires ICAM-1 expression in recipients. 
Anti-IL-10 mAb treatment during the elicitation phase restores LZT 
Keratinocytes are one of the major sources of TNF-, and IL-10 down-regulates 
TNF- production by keratinocytes (McHale et al., 1999; Piguet et al., 1991). 
Keratinocyte-produced TNF- augments endothelial ICAM-1 expression (McHale et 
al., 1999; Piguet et al., 1991). In addition, IL-10 is involved in mediating tolerance 
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induced by LZT (Maurer et al., 2003). Therefore, it is possible that low dose 
tolerization-induced suppressor cells augment local IL-10 release, which is 
responsible for the decreased TNF- production, resulting in a lack of ICAM-1 up-
regulation. To assess this possibility, the effect of IL-10 blockade on LZT was 
examined.  We injected anti-IL-10 mAbs immediately before antigen challenge in 
sensitized mice. First, TNF- production 12 hours after challenge was significantly 
suppressed in low dose tolerized wild type mice as well as in low dose tolerized 
ICAM-1-/- recipients, when compared to CHS responses for each genotype (P < 0.03 
and P < 0.05, respectively, Figure 6a). Intradermal anti-IL-10 mAb injection in 
tolerized wild type mice restored CHS responses to the level observed in normal wild 
type CHS responses. Nonetheless, this restoration by IL-10 blockade was not 
observed in ICAM1-/- mice (Figure 6b). In addition, the restoration of LZT by anti-IL-
10 mAbs was associated with up-regulation of TNF- mRNA (Figure 6c) and ICAM-
1 mRNA (Figure 6d) following antigen challenge. Thus, IL-10 blockade during the 





  In the current study, low dose tolerization effectively suppressed the elicitation 
phase of CHS, which we found to be dependent upon suppressor cells blocking 
ICAM-1 up-regulation. In fact, ICAM-1 up-regulation at the challenge sites was 
abrogated in low dose tolerized wild type mice (Figure 1). LZT was found to be 
lacking in ICAM-1-/- mice, although they could sufficiently generate antigen-specific 
effector cells (Figure 3 and 4). Adoptive transfer studies further indicated that 
tolerized cells inhibited the effector cells during the elicitation phase by an ICAM-1-
dependent mechanism (Figures 5). These findings indicate that LZT associates with 
abrogation of ICAM-1 up-regulation at the challenge site.  
 Previous studies have revealed that ICAM-1 is highly expressed on 
endothelium within the skin (Komura et al., 2003; McHale et al., 1999). Therefore, 
the major source of ICAM-1 mRNA in the current study is likely to be endothelial 
cells. Although several cell types, including keratinocytes, also express ICAM-1 and 
up-regulate ICAM-1 expression during CHS responses (Albanesi et al., 1999; von den 
Driesch et al., 1995). Further studies, such as immunohistchemistry for ICAM-1 
during the elicitation phase, are needed to clarify the issue. Adoptive transfer 
experiments into ICAM-1-/- bone marrow chimeras will be revealing. In the present 
study, enhanced TNF- production following antigen challenge was eliminated by 
low dose tolerization in ICAM-1-/- mice as well as wild type mice (Figure 6). 
Furthermore, blockade of IL-10 abrogated LZT, which was associated with restored 
TNF- and ICAM-1 up-regulation following antigen challenge (Figure 6). 
Collectively, these results indicate that a lack of increased TNF- production 
following antigen challenge is responsible for a lack of endothelial ICAM-1 up-
regulation in LZT. 
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 The results of the present study suggest that ICAM-1 up-regulation critically 
controls CHS responses, although ICAM-1-/- mice generated a certain level of CHS 
responses (Figure 2). The residual CHS responses in ICAM-1-/- mice is likely to be 
regulated by other adhesion molecules including L-selectin, since genetic loss of both 
ICAM-1 and L-selectin inhibited the majority of CHS responses with significant 
reduction of leukocyte infiltration into the skin (Figure 2) (Komura et al., 2003; 
Steeber et al., 1999). It was also noted that low dose tolerization suppressed wild type 
CHS responses to CHS levels in L-selectin-/- mice, which were completely suppressed 
by low dose tolerization. These observations are also consistent with the current 
conclusion that low dose tolerization suppressed ICAM-1 up-regulation without 
affecting the expression of other cell adhesion molecules, including L-selectin. 
Additionally, a role of ICAM-1 in CHS is well-established during leukocyte rolling, 
firm adhesion, and transmigration of leukocytes into sites of inflammation 
(Argenbright et al., 1991). Thus, ICAM-1 expression levels are closely linked to the 
CHS response. 
  Humans generate adaptive immune systems during growth and development, 
which can effectively eliminate pathogens while avoiding immune responses directed 
against self antigens. UV exposure and low dose tolerization help to establish normal 
peripheral tolerance to contact allergens and avoid excessive immune responses 
(Schwarz, 2005). Recently, it has been suggested that UV-induced CD4+CD25+ 
regulatory T cells are the major mediator of UV-induced tolerance, since tolerance 
was transferable to naive recipients by this T cell subset (Aragane et al., 2003; 
Schwarz et al., 2007). However, CD8+ T cells plays a role to suppress the CHS in 
adoptive transfer studies in the present study and the previous work (Steinbrink et al., 
1996). Since CD4+ cells also suppressed the antigen specific proliferative response 
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after the sensitization (Figure 3b), LZT may be coordinately regulated by several 
immune subsets, including CD4+ and CD8+ cells. Multiple studies at various phase of 
CHS may add the information about the mediator of LZT in the future. The 
suppressor cells may suppress the elicitation phase of CHS in an ICAM-1- and IL-10-
dependent manner in both the LZT model utilized in the current study as well as UV-
induced tolerance models (Komura et al., 2003). However, the relationship between 
suppressor cells and ICAM-1 and IL-10 is not clear in this study. Since the elicitation 
phase, but not the sensitization phase, is crucial for LZT-induced suppression of CHS, 
further elucidating the mechanisms of peripheral tolerance regulating the elicitation 
phase will direct clinical approaches for the management of imbalanced adaptive 
immune systems, including autoimmune and allergic diseases. 
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Materials and Methods 
Mice 
ICAM-1-/- mice were obtained from The Jackson Laboratory (Bar Harbor, ME) (Sligh 
Jr. et al., 1993). L-selectin-/- mice and mice lacking both L-selectin and ICAM-1 (L-
selectin/ICAM-1-/-) were generated as described previously (Arbones et al., 1994). 
All mice were healthy, fertile, and did not display evidence of infection or disease. All 
mice were backcrossed between 5 to 10 generations onto the C57BL/6 genetic 
background. Mice used for experiments were 12 to 16 weeks old. Age-matched 
C57BL/6 mice (Jackson Laboratory) were used as controls with equivalent results, so 
all control results were pooled. All mice were housed in a specific pathogen-free 
barrier facility and screened regularly for pathogens. All studies and procedures were 
approved by the Committee on Animal Experimentation of Nagasaki University 
Graduate School of Biomedical Sciences and by the Committee on Animal 
Experimentation of Kanazawa University Graduate School of Medical Science. 
Tolerance induction  
Mice were painted 5 times (on days 0, 2, 4, 6, and 8) with tolerizing doses of 4.5 g 
TNCB (Sigma-Aldrich, St. Louis, MO) in 15 l of 3:1 acetone:olive oil onto shaved 
back skin.  
CHS assay 
On day 10, mice backs were shaved and painted with 450 g TNCB in 15 l 3:1 
acetone:olive oil. On day15, mice were challenged on the dorsal surface of both ears 
with 45 g of 15 l 3:1 acetone:olive oil. Ear thickness was measured with a Peacock 
spring-loaded micrometer (Ozaki, Tokyo, Japan) before and 48 hours after challenge. 
The ear swelling reactions were expressed as the difference between the ear thickness 
 
14 
before and after challenge. Each ear lobe was measured three times at each time point, 
and the mean of those values was used for analysis.  
Adoptive transfer of spleen cells  
Donor mice were exposed 5 times (on days 0, 2, 4, 6, and 8) with tolerizing doses of 
TNCB on shaved backs, and sensitized with TNCB on their shaved backs on day 10. 
Seven days after sensitization, mice were killed, spleens harvested, and single-cell 
suspensions prepared. Viable spleen cells (1x108) were injected into the tail vein of 
naive recipients.  
Enrichment CD8+ and CD4+ T cells for adoptive transfer and proliferative 
responses 
CD8+ and CD4+ T cells were negatively depeleted from whole lymph node cells or 
splenocytes using CD8-corted (for CD4+ enrichment) or CD4-corted (for CD8+ 
enrichment) magnetic beads (Dynal). 
Treatment with anti-IL-10 mAb 
Immediately before antigen challenge, 40 l of anti-IL-10 mAb (JES5.2A5, 1 mg/ml 
in PBS, BD-PharMingen, San Diego, CA) was injected intradermally near the ear 
using a 29-gauge needle under ether anesthesia. Injection of an equal volume of rat 
polyclonal IgG (1 mg/ml in PBS, Sigma) near the ears served as a control. 
Histopathology 
48 hours after antigen challenge, a central strip of the ear was collected, fixed in 3.5% 
paraformaldehyde, and then paraffin embedded. Six-micrometer sections were stained 
using H&E for general histological evaluation.  




Total RNA was isolated from the ear using Pro Green kits (MP Biomedicals, Irvine, 
CA) in accordance with the manufacturer’s protocol. Total RNA was reverse-
transcribed to cDNA using a reverse transcription system with random hexamers 
(Promega, Madison, WI), and mRNA levels of ICAM-1 and TNF- were analyzed by 
real-time RT-PCR using the TaqMan system (Applied Biosystems, Foster City, CA). 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used to normalize mRNA. 
We obtained all sequence-specific primers and probes from TaqMan gene expression 
assays (Applied Biosystems). Real-time PCR was performed on an ABI Prism 7000 
sequence detector or an ABI Prism 7300 sequence detector (Applied Biosystems) 
according to the manufacturer’s instructions. Relative expression of real-time PCR 
products was determined using the CT technique. In brief, we normalized each set of 
samples using the difference in threshold cycle (CT) between the target gene and 
GAPDH: CT = (CT target gene − CT GAPDH). Relative mRNA levels were calculated by the 
formula 2−CT where CT = CT sample (n) − CT calibrator (n). Each reaction was done in 
triplicate. Samples from the same genotype without treatment were chosen as 
calibrator samples. 
In vitro proliferative response to hapten 
To assess in vitro proliferative responses to hapten, splenocytes or cervical and 
inguinal lymph nodes were collected 5 days after TNCB sensitization as previously 
described (Komura et al., 2003). Single-cell suspensions (2x105 cells/well in 0.2 ml) 
were cultured in triplicate in 96-well plates in RPMI 1640 medium (Sigma) 
containing 10% FCS with up to 20 mM TNBS, a water soluble analog of TNCB 
(Sigma). Cellular proliferation was quantified by the addition of 10 M 5-bromo-2'-
deoxyuridine (BrdU; Roche Diagnostics, Mannheim, Germany) during the last 18 
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hours of a 5-day culture, and BrdU incorporation was assayed by ELISA (Roche 
Diagnostics), according to the manufacturer’s instructions. 
Statistical analysis 
The Mann-Whitney U test was used for determining the level of significance of 
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Figure 1. Repeatedly painting tolerizing doses of TNCB affects ICAM-1 mRNA 
production at CHS elicitation sites. mRNA was isolated from the ears 12 hours after 
challenge. ICAM-1 mRNA levels were analyzed by real-time RT-PCR and 
normalized with the GAPDH internal control. Each sample was done in triplicate. 
Data are the mean + SEM. These results represent those obtained with at least 10 
mice in each treatment group. 
Figure 2. Adhesion molecule deficiency impacts LZT. Mice were sensitized with 
TNCB on tolerized back skin following the ear challenge. Ear swelling responses 
were measured after 48 hours. Data are the mean + SD for 5 mice in each group. *P < 
0.05 vs. CHS in wild type mice. **P < 0.01. 
Figure 3. a. ICAM-1 deficient splenocytes proliferate in response to contact antigen. 
Mice were sensitized to TNCB. Five days later, spleens were isolated from mice with 
prior treatment, such as low dose tolerization (tolerized mice), sensitization 
(sensitized mice), and no treatment (CTL). Single-cell suspensions were cultured in 
vitro with varying amounts of TNBS for 5 days. b. ICAM-1 deficient lymphocytes 
proliferate in response to contact antigen. Mice were sensitized to TNCB. Five days 
later, cervical and inguinal lymphocyte were isolated from mice with prior treatment, 
such as low dose tolerization (tolerization), sensitization (sensitization). Single-cell 
suspensions with/without CD8 depletion (for CD4+ cell enrichment) or CD4 depletion 
(for CD8+ cell enrichment) were cultured in vitro with/without 20mM TNBS for 5 
days. Proliferation was assessed by the incorporation of BrdU added during the last 
18 hours of culture. Values represent mean OD ( SEM) from triplicate cultures. 
Results are shown for one of three independent experiments with one mouse of each 
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genotype and treatment. *P < 0.05 vs. CTL in the same genotype. **P < 0.05 in the 
same genotype. 
Figure 4. The role of ICAM-1 during the generation of LZT-induced suppressor cells. 
Naive recipients were adoptively transferred 1x108 splenocytes with/without CD8 
depletion from mice that had been sensitized to TNCB with low dose tolerization 
(tolerized), or without tolerization (sensitized). The recipients were subsequently 
sensitized with TNCB. Five days later, the mice were challenged on the ear and ear 
thickness was measured after 48 hours. Data are the mean + SD for 5 mice per group. 
*P < 0.001 vs. the same genotype receiving splenocytes from sensitized donors. Mice 
without adoptive transfer served as controls (CTL). 
Figure 5. LZT affects the elicitation phase of the CHS response. The presence of 
suppressor cells was assessed by adoptive co-transfer of both effector and suppressor 
cells into naive recipients. Equal numbers (1x108) of tolerized and sensitized donor 
splenocytes were adoptively transferred. Recipients were challenged on the ear 
without sensitization and ear swelling was measured 48 hours later. Data are the mean 
+ SD for 5 mice in each group. *P < 0.05 vs. sensitized donors without tolerization. 
Mice without adoptive transfer served as controls (CTL) 
Figure 6. IL-10 blockade during the elicitation restores LZT. (a) TNF- mRNA 
expression. mRNA was isolated from ears 12 hours after the challenge. mRNA levels 
were analyzed by real-time RT-PCR and normalized with the GAPDH internal 
control. Each sample was done in triplicate. Data are the mean + SEM. These results 
represent those obtained with at least 10 mice in each treatment group. (b) Effect of 
anti-IL-10 mAb injection at the elicitation site of LZT. Immediately before antigen 
challenge, either anti-IL-10 mAb (IL-10 Ab) or rat polyclonal IgG (CTL Ab) was 
injected intradermally near the ear. Ear thickness was measured 48 hours after Ag 
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challenge. Data are the mean + SD for 5 mice in each group. (c) Effect of anti-IL-10 
mAb treatment on TNF- mRNA production. Mice were treated with either IL-10 
Ab or CTL Ab as described above and 12 hours after antigen challenge TNF- 
mRNA expression was evaluated. These results were obtained with 5 mice per 
treatment group. Data are the mean + SEM. (d) Effect of anti-IL-10 mAb treatment 
on ICAM-1 production. Wild type mice were treated with either IL-10 Ab or CTL 
Ab as described above and 12 hours after antigen challenge ICAM-1 mRNA was 
assessed. Data are the mean + SEM. *P < 0.05.  **P < 0.01. 
 
Abbreviations: Ag, antigen; BrdU, 5-bromo-2’-deoxyuridine; CHS, contact 
hypersensitivity; CT, threshold cycle; GAPDH, Glyceraldehyde-3-phosphate 
dehydrogenase; L-selectin-/-, L-selectin-deficient; L-selectin/ICAM-1-/-, lacking both 
ICAM-1 and L-selectin; LZT, low zone tolerance; TNBS, 2,4,6-trinitro-
benzenesulfonic acid; TNCB, 2,4,6-trinitro-1chlorobenzene; TNF, tumor necrosis 
factor; and UV, ultraviolet. 
 






